Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease

World Journal of Gastroenterology

Volumn 14, Issue 13, 2008, Pages 2044-2048

  Mamori, Satoshi ^a   Searashi, Yasuyuki ^a   Matsushima, Masato ^a   Hashimoto, Kenichi ^b   Uetake, Shinichiro ^a   Matsudaira, Hiroshi ^a   Ito, Shuji ^a   Nakajima, Hisato ^a   Tajiri, Hisao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Abdominal ultrasonography; Alcoholic disease; Alcoholism; Esophageal varice; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4;

ABDOMINAL SCINTISCANNING; ADULT; AGE DISTRIBUTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; AREA UNDER THE CURVE; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SPLENOMEGALY;

EID: 44849096382     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2044     Document Type: Article

References (28)

1. Sutton R, Shields R. Alcohol and oesophageal varices. Alcohol Alcohol 1995; 30: 581-589
2. Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38: 266-272
3. D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology 2004; 39: 30-34
4. Groszmann RJ, de Franchis R. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC. Schiff's Disease of the Liver. Philadelphia, New York: Lippincott-Raven, 1999: 387-442
5. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 669-681
6. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, de Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28: 868-880
7. Suzuki A, Mendes F, Lindor K. Diagnostic model of esophageal varices in alcoholic liver disease. Eur J Gastroenterol Hepatol 2005; 17: 307-309
8. Burroughs AK, McCormick PA. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992; 6: 437-450
9. Hosey RG, Mattacola CG, Kriss V, Armsey T, Quarles JD, Jagger J. Ultrasound assessment of spleen size in collegiate athletes. Br J Sports Med 2006; 40: 251-254; discussion 251-254
10. Yoshida H, Mamada Y, Taniai N, Tajiri T. New methods for the management of gastric varices. World J Gastroenterol 2006; 12: 5926-5931
11. Vanbiervliet G, Barjoan-Marine E, Anty R, Piche T, Hastier P, Rakotoarisoa C, Benzaken S, Rampal P, Tran A. Serum fibrosis markers can detect large oesophageal varices with a high accuracy. Eur J Gastroenterol Hepatol 2005; 17: 333-338
12. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-809
13. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354
14. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612
15. Nidegger D, Ragot S, Berthelemy P, Masliah C, Pilette C, Martin T, Bianchi A, Paupard T, Silvain C, Beauchant M. Cirrhosis and bleeding: the need for very early management. J Hepatol 2003; 39: 509-514
16. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002; 122: 1620-1630
17. Castera L, Hartmann DJ, Chapel F, Guettier C, Mall F, Lons T, Richardet JP, Grimbert S, Morassi O, Beaugrand M, Trinchet JC. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J Hepatol 2000; 32: 412-418
18. Guechot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol 1995; 22: 103-106
19. Campbell S, Timms PM, Maxwell PR, Doherty EM, Rahman MZ, Lean ME, Danesh BJ. Effect of alcohol withdrawal on liver transaminase levels and markers of liver fibrosis. J Gastroenterol Hepatol 2001; 16: 1254-1259
20. Annoni G, Colombo M, Cantaluppi MC, Khlat B, Lampertico P, Rojkind M. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 1989; 9: 693-697
21. Lotterer E, Gressner AM, Kropf J, Grobe E, von Knebel D, Bircher J. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity. J Hepatol 1992; 14: 71-77
22. Niemela O, Risteli L, Sotaniemi EA, Risteli J. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 1985; 15: 132-137
23. Niemela O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 1990; 98: 1612-1619
24. Niemela O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Connective tissue metabolism and alcohol intake in alcoholic liver disease. Alcohol Alcohol Suppl 1991; 1: 351-355
25. Nouchi T, Worner TM, Sato S, Lieber CS. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res 1987; 11: 287-291
26. Robert P, Champigneulle B, Kreher I, Gueant JL, Foiguet B, Dollet JM, Bigard MA, Gaucher P. Evaluation of fibrosis in the disse space in noncirrhotic alcoholic liver disease. Alcohol Clin Exp Res 1989; 13: 176-180
27. Antler AS, Pitchumoni CS, Thomas E, Orangio G, Scanlan BC. Gastrointestinal bleeding in the elderly. Morbidity, mortality and cause. Am J Surg 1981; 142: 271-273
28. Segal WN, Cello JP. Hemorrhage in the upper gastrointestinal tract in the older patient. Am J Gastroenterol 1997; 92: 42-46